Connect Biopharma Holdings Limited
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.About CNTB
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease.
CNTB Key Statistics
Stock Snapshot
The current Connect Biopharma Holdings Limited(CNTB) stock price is $2.90, with a market capitalization of 169M. The stock trades at a price-to-earnings (P/E) ratio of -10.57.
On 2026-04-04, Connect Biopharma Holdings Limited(CNTB) stock traded between a low of $2.72 and a high of $3.02. Shares are currently priced at $2.90, which is +6.6% above the low and -4.0% below the high.
Connect Biopharma Holdings Limited(CNTB) shares are trading with a volume of 859.17K, against a daily average of 583.44K.
In the last year, Connect Biopharma Holdings Limited(CNTB) shares hit a 52-week high of $3.82 and a 52-week low of $0.51.
In the last year, Connect Biopharma Holdings Limited(CNTB) shares hit a 52-week high of $3.82 and a 52-week low of $0.51.
CNTB News
Analyst Brandon Folkes from H.C. Wainwright reiterated a Buy rating on Connect Biopharma Holdings and keeping the price target at $7.00. End of Quarter Sale - 5...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.